The safe and efficacy of forward viewing EUS for colorectal tumor

The safe and efficacy of forward viewing EUS for colorectal tumor - The safe and efficacy of forward viewing EUS for colorectal tumor

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035902

Enrollment

Registered

2019-02-17

Start date

2018-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal tumor

Interventions

EUS, which is approved for only upper GI diseases, is used for colorectal diseases.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 known or suspected colorectal tumor 2 colonoscopy scheduled or colonoscopy found colorectal tumor 3 complete informed consent

Exclusion criteria

Exclusion criteria: A. age limitations B. allergy for egg C. incomplete informed consent D. pregnant

Design outcomes

Primary

Measure	Time frame
Matching of images obtained using forward viewing EUS and pathological evaluation for colorectal tumor	—

Countries

Japan

Contacts

Public ContactMasaya Esaki

Nagoya university hospital Department of Endoscopy

em6089@med.nagoya-u.ac.jp0527412172

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026